Brian DeSchuytner
Direttore Finanziario/CFO presso MERSANA THERAPEUTICS, INC.
Patrimonio netto: 127 011 $ in data 31/05/2024
Profilo
Brian DeSchuytner is currently the Senior VP, Chief Operating & Financial Officer at Mersana Therapeutics, Inc. He previously worked as the Vice President-ZEJULA Commercial at Tesaro, Inc. from 2017 to 2019, and as the VP-Global Marketing & Head-Global Brand at Millennium Pharmaceuticals, Inc. from 2009 to 2017.
Mr. DeSchuytner completed his undergraduate degree at Dartmouth College and holds an MBA from The Wharton School of the University of Pennsylvania.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 15/04/2024 | 54 511 ( 0.04% ) | 127 011 $ | 31/05/2024 |
Posizioni attive di Brian DeSchuytner
| Società | Posizione | Inizio |
|---|---|---|
| MERSANA THERAPEUTICS, INC. | Direttore Finanziario/CFO | 10/07/2019 |
Precedenti posizioni note di Brian DeSchuytner
| Società | Posizione | Fine |
|---|---|---|
| TESARO INC | Corporate Officer/Principal | 01/06/2019 |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01/01/2017 |
Formazione di Brian DeSchuytner
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
| Dartmouth College | Undergraduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| MERSANA THERAPEUTICS, INC. | Health Technology |
| Aziende private | 2 |
|---|---|
Tesaro, Inc.
 Tesaro, Inc. Pharmaceuticals: MajorHealth Technology TESARO, Inc. is an oncology-focused biopharmaceutical company, which engages in the research and development of biopharmaceutical products. The firm offers Niraparib products. The company was founded by Leon Oliver Moulder, Jr., Mary Lynne Hedley, and Richard J. Rodgers on March 26, 2010 and is headquartered in Waltham, MA. | Health Technology |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Health Technology |
- Borsa valori
- Insiders
- Brian DeSchuytner
